Precipio Inc. (PRPO)

0.4225 -0.016 (-3.649%)

IEX Real-Time Price

August 17, 2018 EST.

NASDAQ Capital Market : Healthcare

Prev Close 0.4385

Price Open 0.46

Volume: 756,370

Avg Volume: 1.77M

Market Cap: 9.78M

P/E Ratio -

52 Wk Range 0.32-5.6



PRPO Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-07-31
10.94M
1.11M
0.49
10.14%

2018-07-13
10.94M
914,187
1.78
8.36%

2018-06-29
10.94M
868,490
1.23
7.94%

2018-06-15
10.94M
762,209
0.39
6.97%




PRPO Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2017-04-13
Q4 2016
N/A
0.00 (0)
0.00
0.00

News

Precipio reports Q2 results (2018-08-17 07:49 SeekingAlpha)

Precipio (NASDAQ: PRPO ): Q2 EPS of -$0.15. More news on: Precipio, Inc., Earnings news and commentary, Tech stocks news, , Read more …

 


Statistics

Shares Outstanding: 19.67M

Top 15 Institution Percent: 9.10

Price To Sales: 4.49

Price To Book: 0.73

Revenue: N/A

Gross Profit: N/A

Cash: N/A

Debt: N/A

Return On Assets: -281.12

Return On Equity: 1061.32

Profit Margin: N/A

Price History

Beta: 0.18

50-day Moving Avg: 0.41

200-day Moving Avg: 0.74

YTD Change: -63.26

5-day Change: -4.22

1-month Change: 14.19

3-month Change: -1.47

6-month Change: -41.32

1-year Change: -91.58

Revenue Per Share: 0.00

Revenue Per Employee: 0.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Precipio Inc.

Exchange: NASDAQ Capital Market

Industry: Medical Diagnostics & Research

Sector: Healthcare

Website: http://www.precipiodx.com

Precipio Inc is a diagnostics company, which has built a platform designed to eradicate the problem of misdiagnosis by harnessing the expertise and technology developed within academic institutions and delivering diagnostic information to physicians.